The University of Chicago Header Logo

Connection

Michelle A. Josephson to Immunosuppressive Agents

This is a "connection" page, showing publications Michelle A. Josephson has written about Immunosuppressive Agents.
  1. Women and transplantation: fertility, sexuality, pregnancy, contraception. Adv Chronic Kidney Dis. 2013 Sep; 20(5):433-40.
    View in: PubMed
    Score: 0.310
  2. Leflunomide in renal transplantation. Expert Rev Clin Immunol. 2011 May; 7(3):273-81.
    View in: PubMed
    Score: 0.264
  3. Rabbit antithymocyte globulin or basiliximab for induction therapy? N Engl J Med. 2006 Nov 09; 355(19):2033-5.
    View in: PubMed
    Score: 0.194
  4. Pregnancy in recipients of solid organs--effects on mother and child. N Engl J Med. 2006 Mar 23; 354(12):1281-93.
    View in: PubMed
    Score: 0.185
  5. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation. 2006 Mar 15; 81(5):704-10.
    View in: PubMed
    Score: 0.185
  6. Leflunomide in solid organ transplantation and polyoma virus infection. Adv Exp Med Biol. 2006; 577:255-65.
    View in: PubMed
    Score: 0.182
  7. Bone disease after kidney transplantation. Semin Nephrol. 2004 Jan; 24(1):82-90.
    View in: PubMed
    Score: 0.159
  8. The Epidemiologic Burden of Tacrolimus Variability among Kidney Transplant Recipients in the United States. Am J Nephrol. 2019; 50(5):370-374.
    View in: PubMed
    Score: 0.118
  9. Establishing a Core Outcome Measure for Life Participation: A Standardized Outcomes in Nephrology-kidney Transplantation Consensus Workshop Report. Transplantation. 2019 06; 103(6):1199-1205.
    View in: PubMed
    Score: 0.116
  10. Pregnancy in chronic kidney disease and kidney transplantation. Kidney Int. 2017 05; 91(5):1047-1056.
    View in: PubMed
    Score: 0.099
  11. Impact of immunosuppression on recall immune responses to influenza vaccination in stable renal transplant recipients. Transplantation. 2014 Apr 27; 97(8):846-53.
    View in: PubMed
    Score: 0.081
  12. Late kidney dysfunction in a kidney transplant recipient. Clin J Am Soc Nephrol. 2014 Mar; 9(3):590-7.
    View in: PubMed
    Score: 0.079
  13. Pregnancy in the renal transplant recipient. Obstet Gynecol Clin North Am. 2010 Jun; 37(2):211-22.
    View in: PubMed
    Score: 0.062
  14. Considerations in the medical management of pregnancy in transplant recipients. Adv Chronic Kidney Dis. 2007 Apr; 14(2):156-67.
    View in: PubMed
    Score: 0.050
  15. Reproduction and pregnancy in transplant recipients: current practices. Prog Transplant. 2006 Jun; 16(2):127-32.
    View in: PubMed
    Score: 0.047
  16. Calcium and calcitriol prophylaxis attenuates posttransplant bone loss. Transplantation. 2004 Oct 27; 78(8):1233-6.
    View in: PubMed
    Score: 0.042
  17. Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity. Am J Kidney Dis. 1999 Jul; 34(1):69-84.
    View in: PubMed
    Score: 0.029
  18. Pregnancy in a nonimmunosuppressed transplant recipient. Am J Kidney Dis. 1998 Oct; 32(4):661-3.
    View in: PubMed
    Score: 0.028
  19. Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation. Transplant Proc. 1998 Jun; 30(4):1538-40.
    View in: PubMed
    Score: 0.027
  20. Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation. Transplant Proc. 1998 Mar; 30(2):507-8.
    View in: PubMed
    Score: 0.026
  21. Reversal of accelerated renal allograft rejection with FK 506. Clin Transplant. 1997 Aug; 11(4):251-4.
    View in: PubMed
    Score: 0.025
  22. Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal. Transplant Proc. 1997 Feb-Mar; 29(1-2):307.
    View in: PubMed
    Score: 0.025
  23. Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies. Transplantation. 1996 Oct 15; 62(7):906-10.
    View in: PubMed
    Score: 0.024
  24. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Clin Transplant. 1996 Aug; 10(4):323-32.
    View in: PubMed
    Score: 0.024
  25. OKT3 escalating dose regimens provide effective therapy for renal allograft rejection. Clin Transplant. 1996 Aug; 10(4):389-95.
    View in: PubMed
    Score: 0.024
  26. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506. Transplant Proc. 1996 Apr; 28(2):998-9.
    View in: PubMed
    Score: 0.023
  27. Low-dose anti-CD3 therapy provides long-term graft survival in a Lewis rat to C57BL/6 xeno-islet transplantation model. Transplant Proc. 1994 Apr; 26(2):771-3.
    View in: PubMed
    Score: 0.020
  28. Treatment of de novo and recurrent membranous nephropathy in renal transplant patients. Semin Nephrol. 2003 Jul; 23(4):392-9.
    View in: PubMed
    Score: 0.010
  29. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. Hum Pathol. 2001 Feb; 32(2):205-15.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.